IMAX Outpaces Rivals

Benzinga

IMAX shares surged more than 44% in 2025 as the company posted record global box office revenue, outperforming rival theater stocks struggling with weaker attendance and streaming competition.

Transcript

00:00It's Benzinga, bringing Wall Street to Main Street.

00:02IMAX shares rose more than 44% in 2025, outpacing other theater stocks,

00:08even before the company reported a record $1.28 billion in global box office revenue for the year,

00:14according to CNBC. Ticket sales rose more than 40% from 2024 and exceeded the prior 2019 record

00:21by 13%. AMC, Cinemark, and Marcus Theatres posted sharp stock declines as theater operators faced

00:28lower overall box office totals and shifting consumer behavior towards streaming. Domestic

00:33ticket sales remained about 25% below 2018 levels, and the 2025 box office missed analyst expectations.

00:41IMAX benefited from demand for premium large format theaters, higher ticket prices, an asset light

00:47model, and consistent profitability, reporting $43 million in net income through the first nine

00:52months of 2025. For all things money, visit Benzinga.com.

Category

Transcript

Be the first to comment

Recommended